Skip to main content

Table 3 The patients’ clinical and radiographic manifestations according to pulmonary CMV infection status

From: Outcomes and prognostic factors of non-HIV patients with pneumocystis jirovecii pneumonia and pulmonary CMV co-infection: A Retrospective Cohort Study

  CMV-DNA positive in BALF CMV-DNA negative in BALF p
Symptoms, n (%)
fever 31 (81.6%) 28 (87.5%) 0.50
dyspnea 29 (76.3%) 17 (53.1%) 0.04
CT findings
ground-glass opacities 38/38 (100.0%) 32/32 (100.0%) 1.00
consolidations 18/38 (47.4%) 15/32 (46.9%) 0.97
centrilobular nodules 14/38 (36.8%) 3/32 (9.4%) 0.008
upper lobe predominance 7/38 (18.4%) 8/32 (25.0%) 0.50
  1. CMV cytomegalovirus, BALF bronchoalveolar lavage fluid, CT computed tomography